Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hodgkin Disease × Neuropsychological Tests × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 12 Cognitive Dysfunction 4 Radiation Injuries 3 Neoplasms 3 Glioma 3 Multiple Myeloma 2 Lymphoma, B-Cell 2 Glioblastoma 2 Fatigue 2 Breast Neoplasms 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Pituitary Neoplasms 1 Parkinson Disease 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Localized, Operable Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Hodgkin Disease 1

Interventions

Cyclophosphamide 154 fludarabine phosphate 96 Peripheral Blood Stem Cell Transplantation 80 Etoposide 77 Mycophenolic Acid 74 Whole-Body Irradiation 71 Melphalan 62 fludarabine 59 Tacrolimus 59 Filgrastim 59 Busulfan 58 Radiotherapy 52 Doxorubicin 50 Rituximab 49 Cyclosporine 47 Brentuximab Vedotin 44 Antilymphocyte Serum 40 Vinblastine 38 Granulocyte Colony-Stimulating Factor 37 Gemcitabine 34 Dacarbazine 33 Methotrexate 32 Cytarabine 32 Bleomycin 28 Nivolumab 26 Carmustine 26 Vincristine 24 Sirolimus 24 Prednisone 24 Bendamustine Hydrochloride 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116929 2024-02-28

FunC-AHOD

Lille Catholic University

Phase NA Not yet recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡